Study Shows Bio/Pharma Patents Fare Better at PTAB
A few years back, the Patent Trial & Appeal Board (PTAB) released a study showing the outcome of proceedings directed to so-called “Orange Book” patents. That study demonstrated that Orange book/Biologic patents were more likely to survive PTAB proceedings relative to other patents. Last week, the 2018 study was updated.
The update shows the performance of Orange Book/Biologic patents at the PTAB since 2012.
Continue Reading Bio/Pharma Patents Fare Best at PTAB